- Palabras clave > antibacterial resistance (ABR)
- Palabras clave > antibiotic resistance
- Palabras clave > antimicrobial resistance (AMR)
- Palabras clave > antimicrobial resistance surveillance
- Palabras clave > containment of antimicrobial resistance
- Palabras clave > drug resistance, microbial
- Palabras clave > resistance - antibacterial drugs
- Palabras clave > surveillance - antibiotic resistance and antibiotic use
- Palabras clave > confinement antimicrobien
(2015; 56 pages)
Antimicrobial resistance (AMR) is a global public health threat of high concern in the Western Pacific Region. The 2014 World Health Assembly resolution WHA67.25 stresses the need for urgent action to combat AMR. In the Western Pacific Region, priority actions to contain AMR were identified by the World Health Organization (WHO) in consultation with Member States. These actions are outlined in the Action Agenda for Antimicrobial Resistance in the Western Pacific Region which was endorsed by the sixty-fifth session of the Regional Committee for the Western Pacific. The action agenda provides a background to AMR in the Region and highlights challenges in addressing this public health threat.
Antimicrobial Resistance in the Western Pacific Region: A review of Surveillance and Health Systems Response provides an in-depth situational review and technical discussion in three main areas for the containment of AMR in the Region:
- Surveillance of AMR in the Western Pacific Region.
- Monitoring of antimicrobial use in the Western Pacific Region.
- Health systems response to support containment of AMR in the Western Pacific Region.
Part 1 describes the progress in the Region on surveillance of AMR and the gaps in laboratory capacity and methodologies. Part two highlights the need to monitor antimicrobial use through common methodologies and indicators, in addition to surveillance of AMR, to inform important policy changes to contain AMR. The health systems response to AMR also varies across the Region. Part three highlights the urgent need to strengthen regulation of pharmaceutical systems, antimicrobial stewardship and infection prevention and control (IPC) to contain AMR in the Region.